ZOTA.NSE · Zota Health Care Limited

-

Please sign in to comment on ZOTA.NSE

1 Comment

Admin

4 years, 1 month ago

Zota Health Care Limited is currently in a long term uptrend where the price is trading 49.6% above its 200 day moving average.

From a valuation standpoint, the stock is 20.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.

Zota Health Care Limited's total revenue rose by 21.6% to $305M since the same quarter in the previous year.

Its net income has dropped by 365.1% to $-10M since the same quarter in the previous year.

Finally, its free cash flow fell by 124.8% to $-5M since the same quarter in the previous year.

Based on the above factors, Zota Health Care Limited gets an overall score of 3/5.

CurrencyCode	INR
ISIN	INE358U01012
Exchange	NSE
Sector	Healthcare
Industry	Biotechnology

Market Cap	21B
PE Ratio	None
Target Price	None
Dividend Yield	0.1%
Beta	0.36

ABOUT

Zota Health Care Limited

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, wellness, over-the-counter products, ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, heart disease, and thyroid disorders. It operates its retail stores under the DAVAINDIA name. The company also exports its products. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.

ZOTA.NSE · Zota Health Care Limited

-

Zota Health Care Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Zota Health Care Limited using a moving average strategy